Free Newsletter
Roche wins round in battle for Ventana
Hostile takeovers are no fun to be part of but they're exciting to watch. Roche won the latest round in its bid for Ventana Medical Systems: An Arizona court granted an injunction against Ventana's use of anti-takeover statutes to block Roche's bid for the company.
You'll recall that Roche made a tender offer for Ventana back in June at a price of $75 per share; the previous trading day, Ventana stock had closed at $51.95. In July, the Ventana board told shareholders not to cash in their shares because the Roche offer was "inadequate." Just yesterday, Roche extended its offer through September 20; only some 13,500 shareholders had tendered their stock--and Ventana has 35.6 million shares outstanding. Ventana shares are now trading at $82.51.
- see the release
- check out the AP report
Related Articles:
Roche note opens door to a higher Ventana bid. Report
Ventana spurns Roche's $3B hostile takeover bid. Report
Ventana shares soar on hostile $3B bid. Report
Roche shakes up R&D, eyes new buyouts. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment